FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Source Type: news
More News: Azithromycin | Cancer | Cancer & Oncology | Drugs & Pharmacology | Stem Cell Therapy | Stem Cells | Transplants | Zithromax